Oncolytic Viral Therapeutic

Challenge

A sponsor organization developed a novel oncolytic viral therapeutic of genetically engineered herpes simplex virus type 1 (HSV-1) targeted to treat glioblastoma. Battelle was contracted to complete a good laboratory practice (GLP), investigational new drug (IND)-enabling study, evaluating the toxicity, biodistribution and efficacy of the therapeutic in a human orthotopic xenograft model.

Solution

Battelle developed and validated a quantitative polymerase chain reaction (qPCR) assay in mouse blood and tissue matrices using a plasmid construct containing the target as positive control. The validated assay detected as few as five target copies per microgram of DNA with 95% confidence and met other strict criteria for specificity, accuracy and precision.

The test article was administered directly to the brain of immunocompromised preclinical models. 

Impact

Battelle demonstrated low/no biodistribution of the oncolytic virus outside the target brain tissue. 

The FDA approved the IND application and allowed progression of the oncolytic viral therapeutic into phase I clinical trials.
Connect with an expert

Related Expertise

Cross-disciplinary scientific and engineering collaboration is essential for innovation. Our experts, called “Solvers” at Battelle, combine multiple advanced materials expertise like these with other applied sciences and engineering disciplines to deliver comprehensive client solutions.

  • Materials Chemistry

Our comprehensive solutions require cross-disciplinary scientific and engineering collaboration. Battelle Solvers combine biology disciplines like these with other applied sciences and engineering to deliver client success.

  • Bioaerosol Science

  • Biomedical Engineering

  • Biostatistics

  • Genomics

  • Virology

Innovation requires multidisciplinary scientific and engineering collaboration. Our Solvers at Battelle combine multiple chemistry disciplines like these with other applied sciences and engineering expertise to deliver comprehensive client solutions.
Data science expertise is at the core of our multidisciplinary approach. Our experts, called “Solvers” at Battelle, combine data science disciplines like these with applied engineering and science to deliver comprehensive client solutions in government and industry.

  • Artificial Intelligence

  • Biostatistics

  • Data Analytics

  • Data Translation

  • Modeling and Simulation

Real-world solutions require multidisciplinary scientific and engineering collaboration. Our experts, called “Solvers” at Battelle, combine multiple engineering disciplines like these with other applied sciences to deliver comprehensive client solutions.

  • Biomedical Engineering

  • Chemical Engineering

  • Electrical Engineering

  • Genetic Engineering

  • Human Factors Engineering

  • Mechanical Engineering

  • Medical Device Engineering

  • Modeling and Simulation

  • Systems Engineering

Andre LaFreniere Vice President, Commercial Business Development and Sales, Battelle Health

Book Time

Schedule Time

At Battelle, solving tough challenges is what we do. Let us know how we can help you. Let’s connect.